Axsome Therapeutics's total assets for Q1 2026 were $713.61M, an increase of 3.45% from the previous quarter. AXSM total liabilities were $659.02M for the fiscal quarter, a 9.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.